Insider Trading Alert - ABCO, SKX And OSIS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 12, 2014, 84 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $10,031,220.00.

Highlighted Stocks Traded by Insiders:

Advisory Board (ABCO) - FREE Research Report

Farber Evan R, who is General Counsel at Advisory Board, sold 1,992 shares at $47.40 on Sept. 12, 2014. Following this transaction, the General Counsel owned 1,996 shares meaning that the stake was reduced by 49.95% with the 1,992-share transaction.

The shares most recently traded at $49.52, up $2.12, or 4.28% since the insider transaction. Historical insider transactions for Advisory Board go as follows:

  • 4-Week # shares sold: 1,333
  • 12-Week # shares sold: 2,666
  • 24-Week # shares sold: 5,332

The average volume for Advisory Board has been 243,300 shares per day over the past 30 days. Advisory Board has a market cap of $1.8 billion and is part of the services sector and diversified services industry. Shares are down 21.41% year-to-date as of the close of trading on Friday.

The Advisory Board Company provides best practices research and analysis, business intelligence and performance technology software, and consulting and management services to the health care and education industries in the United States and internationally. The company has a P/E ratio of 101.2. Currently, there are 10 analysts who rate Advisory Board a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ABCO - FREE

TheStreet Quant Ratings rates Advisory Board as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Advisory Board Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Elliott Notches Win at Advisory Board, Monitors Progress with NRG - ICYMI

Advisory Breaks Up and Sells Following Elliott Campaign

Wall Street Weighs In on Athenahealth's Strategic Options

Singer's Elliott Management Eyes 'Strategic Opportunities' at Athenahealth

Elliott Settles With Advisory Board as Strategic Review Continues